LNSR on Nasdaq

LENSAR, Inc.

We are a commercial-stage medical device company focused on designing, developing and marketing advanced laser systems for the treatment of cataracts and the management of pre-existing or surgically.3 From its latest annual report

Price unavailable

Last updated Oct 19, 2026.

Overview

Compare with CARLSMED, INC., Apyx Medical Corp or SHOULDER INNOVATIONS, INC., or pick any stock.

  • TickerLNSR on Nasdaq1
  • IndustrySurgical & Medical Instruments & Apparatus1
  • HeadquartersOrlando, Florida1
  • Incorporated inDE2
  • Business address2800 Discovery Drive, Suite 100, Orlando, Fl 328262
  • Filer categoryNon-accelerated filer, Smaller reporting company2
  • Legal formCorporation

See how the biggest companies compare on our leaderboards

We are a commercial-stage medical device company focused on designing, developing and marketing advanced laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Our current systems, the LENSAR Laser System, or LLS, and ALLY Robotic Cataract Laser System ® , or ALLY System, or collectively, the Systems, incorporate a range of proprietary technologies designed to assist the surgeon in obtaining better visual outcomes, efficiency and reproducibility by providing advanced imaging, simplified procedure planning, efficient design and precision. We believe the cumulative effect of these technologies results in laser systems that can be quickly and efficiently integrated into a surgeon’s existing practice, is easy to use and provides surgeons the ability to deliver improved visual outcomes with enhanced precision and the ability …3 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

-47.6%Operating margin4
-66.4%Net margin4
12.4%Revenue growth, 20254
-$14.9MFree cash flow4

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

Product brought in 89% of the revenue LENSAR, Inc. broke down this way in fiscal 2025.

  1. Product$45.9M489%up 12% from 2024
  2. Service$5.7M411%up 17% from 2024
Products and services by year
Products and services20242025
Product$41.1M$45.9M
Service$4.9M$5.7M

Regions

United States brought in 66% of the revenue LENSAR, Inc. broke down this way in fiscal 2025.

  1. United States$34.3M466%up 19% from 2024
  2. Europe$8.4M416%down 17% from 2024
  3. Asia Excluding South Korea$8.0M416%up 46% from 2024
  4. South Korea$658.0K41%down 22% from 2024
  5. Other Geographical Region$238.0K40%down 58% from 2024
Regions by year
Regions20242025
United States$28.9M$34.3M
Europe$10.2M$8.4M
Asia Excluding South Korea$5.5M$8.0M
South Korea$848.0K$658.0K
Other Geographical Region$563.0K$238.0K

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue38¢$31.3M
  • Research and development7¢$5.6M
  • Selling, general and admin55¢$45.2M

Out of $51.7M in revenue.4 The company lost money this year.

Financial statements

Revenue567894$51.7M in 2025+96% since 2019
0$20.0M$40.0M$60.0M2019: $26.3M$26.3M20192020: $22.8M$22.8M2020−14%2021: $29.5M$29.5M2021+29%2022: $29.4M$29.4M2022−0%2023: $35.7M$35.7M2023+21%2024: $46.0M$46.0M2024+29%2025: $51.7M$51.7M2025+12%
Operating income567894-$24.6M in 2025+93% since 2019
-$30.0M-$20.0M-$10.0M02019: -$12.7M-$12.7M20192020: -$18.5M-$18.5M2020+46%2021: -$19.7M-$19.7M2021+6%2022: -$20.2M-$20.2M2022+3%2023: -$12.2M-$12.2M2023−39%2024: -$10.7M-$10.7M2024−13%2025: -$24.6M-$24.6M2025+130%
Net income567894-$34.3M in 2025+134% since 2019
-$40.0M-$30.0M-$20.0M-$10.0M02019: -$14.7M-$14.7M20192020: -$19.8M-$19.8M2020+35%2021: -$19.6M-$19.6M2021−1%2022: -$19.9M-$19.9M2022+2%2023: -$14.4M-$14.4M2023−28%2024: -$31.4M-$31.4M2024+118%2025: -$34.3M-$34.3M2025+9%

Every line of the income statement as filed: the last 2 fiscal years, latest first.4

Period ending2025-12-312024-12-31
Product and service revenue$51.7M$46.0M
Lease$6.8M$7.5M
Total revenue$58.4M$53.5M
Total cost of revenue$31.3M$27.6M
Selling, general and administrative expenses$45.2M$26.5M
Research and development expenses$5.6M$5.3M
Amortization of intangible assets$921.0K$970.0K
Impairment of intangible assets$0$3.7M
Total operating expenses$51.7M$36.5M
Operating loss-$24.6M-$10.7M
Change in fair value of warrant liabilities-$10.3M-$21.4M
Other income, net$636.0K$660.0K
Net loss-$34.3M-$31.4M
Change in unrealized gain on investments-$2.0K$2.0K
Net loss and comprehensive loss-$34.3M-$31.4M
Basic-$2.87-$2.73
Diluted-$2.87-$2.73
Basic12.0M shares11.5M shares
Diluted12.0M shares11.5M shares

Compare LENSAR, Inc. with another company

Leadership

Who has led LENSAR, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Nicholas T. Curtis2020–now

Chief financial officer

  1. Thomas R. Staab Ii.2020–2026
  2. Michael A. Rossi2026–now

Chief operating officer

  1. Alan B. Connaughton2020–now
2025
Board members and other officers (9)

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • DirectorJohn P. McLaughlin named May 26, 202324

Former names

  • LensAR IncJun 29, 2007 to Jan 14, 20152
  • LaserSoft Vision IncMar 8, 2005 to Jun 16, 20062

Timeline

  1. Sep 17, 2020New chief executive Nicholas T. Curtis becomes CEO12

Filings

224 filings to the SEC since October 2021: 7 annual reports, 15 quarterly reports, 51 major events, 86 insider forms, 24 large holders, 1 private raises, 40 other. The latest 20:

  1. Aug 13, 202610-Q EDGAR
  2. Aug 13, 20268-K EDGAR
  3. Aug 10, 20268-K EDGAR
  4. Jul 29, 2026SCHEDULE 13G/A EDGAR
  5. Jun 23, 2026DEFA14A EDGAR
  6. Jun 23, 2026ARS EDGAR
  7. Jun 23, 2026DEF 14A EDGAR
  8. Jun 5, 20264 EDGAR
  9. Jun 5, 20264 EDGAR
  10. Jun 5, 20264 EDGAR
  11. Jun 5, 20264 EDGAR
  12. Jun 5, 20264 EDGAR
  13. Jun 5, 20264 EDGAR
  14. Jun 5, 20264 EDGAR
  15. Jun 5, 20264 EDGAR
  16. Jun 5, 20264 EDGAR
  17. Jun 5, 20264 EDGAR
  18. Jun 5, 20263 EDGAR
  19. Jun 2, 2026S-8 EDGAR
  20. May 29, 20268-K EDGAR

The 224 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

28 open-market trades by officers, directors and large owners since October 2021: 28 buys and 0 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Sep 3, 2024Winer Gary MDirectorBuy685$4.50$3.1KForm 4
Aug 28, 2024Winer Gary MDirectorBuy1,000$4.45$4.5KForm 4
Aug 27, 2024Winer Gary MDirectorBuy500$4.50$2.2KForm 4
Aug 26, 2024Winer Gary MDirectorBuy802$4.58$3.7KForm 4
Aug 22, 2024Winer Gary MDirectorBuy2$4.30$9Form 4
Aug 21, 2024Winer Gary MDirectorBuy500$4.35$2.2KForm 4
Aug 20, 2024Winer Gary MDirectorBuy500$4.20$2.1KForm 4
Aug 16, 2024Winer Gary MDirectorBuy6$4.03$24Form 4
Aug 14, 2024Winer Gary MDirectorBuy1,000$4.20$4.2KForm 4
Aug 12, 2024Winer Gary MDirectorBuy500$4.03$2.0KForm 4
Nov 22, 2023Winer Gary MDirectorBuy300$2.10$630Form 4
Nov 16, 2023Winer Gary MDirectorBuy1,000$2.13$2.1KForm 4
Nov 15, 2023Winer Gary MDirectorBuy500$2.15$1.1KForm 4
Nov 10, 2023Winer Gary MDirectorBuy1,000$2.14$2.1KForm 4
Aug 11, 2023Winer Gary MDirectorBuy705$3.60$2.5KForm 4
Aug 10, 2023Winer Gary MDirectorBuy1,000$3.66$3.7KForm 4
May 22, 2023WEISNER AIMEE SDirectorBuy16,647$2.75$45.8KForm 4
May 19, 2023WEISNER AIMEE SDirectorBuy22,153$2.59$57.4KForm 4
May 18, 2023WEISNER AIMEE SDirectorBuy7,700$2.61$20.1KForm 4
May 17, 2023WEISNER AIMEE SDirectorBuy3,500$2.29$8.0KForm 4

All 28 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Money raised

Private offerings the company reported to the SEC on Form D.

  1. May 12, 2023Raised $20 million in a private offering of equity Form D: 1 investor so far Form D

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 76. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Brandes Investment Partners, LP1,075,400$6.1M0.0%+50,224
Vanguard Capital Management LLC402,806$2.3M0.0%+12,716
Groupe la Francaise213,537$1.2M0.0%No change
RBF Capital, LLC188,661$1.1M0.0%+143,134
BlackRock, Inc.185,033$1.1M0.0%−443,715
Css Llc/il163,450$933.3K0.1%No change
Dimensional Fund Advisors LP151,609$865.7K0.0%−73,325
Credit Industriel Et Commercial144,359$824.3K0.1%No change
Kerrisdale Advisers, LLC139,390$795.9K0.2%No change
Millennium Management LLC120,680$689.1K0.0%+108,115
DCF Advisers, LLC118,217$675.0K0.2%No change
Evernest Financial Advisors, LLC118,100$674.4K0.1%+52,100
Geode Capital Management, LLC114,331$653.2K0.0%−115,409
UBS Group AG85,634$489.0K0.0%+2,362
Yakira Capital Management, Inc.83,288$475.6K0.1%No change
State Street Corp80,983$462.4K0.0%−54,757
Man Group plc77,962$445.2K0.0%+2,906
Deltec Asset Management LLC65,000$371.1K0.1%No change
Alpine Global Management, LLC59,569$340.1K0.1%−15,431
Goldman Sachs Group Inc59,529$339.9K0.0%−47,366
Gabelli Funds LLC59,000$336.9K0.0%No change
Vanguard Fiduciary Trust Co57,831$330.2K0.0%−7,829
Dynamic Technology Lab Private Ltd54,166$309.0K0.1%No change
Essex Investment Management Co LLC53,258$304.1K0.0%+23,224
Centiva Capital, LP49,252$281.2K0.0%+3,052

13F reports cover disclosed long positions in U.S. stocks only.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32